Early renal and vascular changes in ADPKD patients with low-grade albumin excretion and normal renal function

Nephrology Dialysis Transplantation

Volumn 24, Issue 8, 2009, Pages 2458-2463

  Azurmendi, Pablo J ^a   Fraga, Adriana R ^a   Galan, Felicita M ^a   Kotliar, Carol ^b   Arrizurieta, Elvira E ^a   Valdez, Marta G ^a   Forcada, Pedro J ^b   Stefan, Jose S Santelha ^a   Martin, Rodolfo S ^a,b  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

Albuminuria; Autosomal dominant polycystic kidney disease; Carotid intima media thickness; Endothelial dependent vascular relaxation; Monocyte chemoattractant protein 1

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; CREATININE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HEART MUSCLE RELAXATION; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN URINE LEVEL; PULSE WAVE;

ADULT; ALBUMINURIA; BRACHIAL ARTERY; CHEMOKINE CCL2; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PULSE; VASODILATION;

EID: 67651102712     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp136     Document Type: Article

References (33)

1. Iglesias DM, Martin RS, Fraga A et al. Genetic heterogeneity of autosomal dominant polycystic kidney disease in Argentina. J Med Genet 1997; 34: 827-830
2. Azurmendi P, Fraga A, Muchnik C et al. Progresión de la poliquistosis renal autonómica dominante. Influencia de polimorfismos de genes de sintasa endotelial del óxido nítrico (ecNOS) y del sistema renina angiotensina. Medicina (Buenos Aires) 2004; 64: 139 - 142
3. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007; 369: 1287-1301
4. Cowley BD Jr, Ricardo SD, Nagao S et al. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int 2001; 60: 2087-2096
5. Zheng D, Wolfe M, Cowley BD Jr et al. Urinary excretion of monocyte-chemoattractant protein 1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2003; 14: 2588-2595
6. Chapman AB, Johnson AM, Gabow PA et al. Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1994; 5: 1349-1354
7. Martinez-Vea A, Gutierrez C, Bardaji A et al. Microalbuminuria in normotensive patients with autosomal-dominant polycystic kidney disease. Scand J Urol Nephrol 1998; 32: 356-359
8. Martinez-Vea A, Bardaji A, Gutierrez C et al. Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state. Am J Kidney Dis 2004; 44: 216-223
9. Wang D, Iversen J, Strandgaard S. Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2000; 11: 1371-1376
10. Kocaman O, Oflaz H, Yekeler E et al. Endothelial dysfunction and increased carotid intima - media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2004; 43: 854 - 860
11. Oflaz H, Alisir S, Buyukaydin B et al. Biventricular diastolic dysfunction in patients with autosomal dominant polycystic kidney disease. Kidney Int 2005; 68: 2244-2249
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266
13. Ravine D, Gibson RN, Walker RG et al. Evaluation of ultrasono-graphic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-827
14. Arnlov J, Evans JC, Meigs JB et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112:969-975
15. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int 2006; 70: 1214-1222
16. Forman JP, Fisher NDL, Schopick EL et al. Higher levels of albuminuria within the normal range predict incident hypertension. J Am Soc Nephrol 2008; 19: 1983-1988
17. Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis, and renal biopsy. In: Brenner BM (ed.). The Kidney. 6th edn. Philadelphia: W.B. Saunders, 2000, p. 1152
18. Roman MJ, Naqvi TZ, Gardin JM et al. American Society of Echocar-diography; Society of Vascular Medicine and Biology. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006; 19:943-954
19. Corretti MC, Anderson TJ, Benjamin EJ et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265
20. Asmar R, Benetos A, Topouchian J et al. Assessment of arterial dis-tensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490
21. Sharp C, Johnson A, Gabow P. Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1998; 9: 1908-1914
22. Stevens LA, Coresh J, Feldman HI et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18: 2749-2757
23. Qian Q, Li M, Cai Y et al. Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol 2004; 14: 2280-2287
24. Naulism SM, Kawanabe Y, Kaminsky JJ et al. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 2008; 117: 1161 - 1171
25. Clausen P, Feldt-Rasmussen B, Iversen J et al. Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease. Am J Nephrol 2006; 26: 335 - 339
26. Wang D, Iversen J, Wilcox CS et al. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal dominant polycystic kidney disease. Kidney Int 2003; 64: 1381 - 1388
27. Borresen ML, Wang D, Strandgaard S. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am J Nephrol 2007; 27: 240-246
28. Flynn FV, Lapsley M, Sampson PA et al. Urinary excretion of beta-2 glycoprotein-1(apolipoprotein H) and other markers of tubular malfunction in 'non-tubular' renal disease. J Clin Pathol 1992; 45: 561-567
29. Casal JA, Hermida J, Lens XM et al. A comparative study of three biomarker tests in autosomal dominant polycystic kidney disease. Kidney Int 2005; 68: 948-954
30. Kannel WB, Kannel C, Paffenbarger RS Jr et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-1494
31. Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997; 11: S19-S27
32. Chonchol M, Goldenberg I, Moss AJ et al. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Am J Nephrol 2007; 27: 7 - 14
33. Zoccali C, Mallamaci F, Parlongo S et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359